-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Psilocybin in Anxiety Disorders
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Psilocybin in Anxiety Disorders report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Psilocybin in Anxiety Disorders Drug Details: Psilocybin is under development for...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Psilocybin in Depression
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Psilocybin in Depression report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Psilocybin in Depression Drug Details: Psilocybin is under development for the treatment...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – UCART20x22 in Marginal Zone B-cell Lymphoma
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - UCART20x22 in Marginal Zone B-cell Lymphoma report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. UCART20x22 in Marginal Zone B-cell Lymphoma Drug Details: Gene...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – SAR-443216 in Solid Tumor
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - SAR-443216 in Solid Tumor report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data.SAR-443216 in Solid Tumor Drug Details:SAR-443216 is under development for the treatment of...
-
Thematic Analysis
Digital Therapeutics – Thematic Intelligence
Explore actionable trends and insights with the following data sets in the ‘Digital Therapeutics’ report: Market analysis of approved and reimbursed digital therapeutic products by region. Case studies with in-depth insight into some of the most recent and most influential developments in the digital therapeutics theme. Product profiles of disruptive digital therapeutic products across key therapeutic areas. A focused chapter on the key healthcare, technology, macroeconomic, and regulatory trends impacting digital therapeutics, and a review of how these trends will...
-
Product Insights
Depression Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Depression is a mood disorder that causes a persistent feeling of sadness and loss of interest. Its signs and symptoms include sleep disturbances, including insomnia or sleeping too much, appetite changes, anxiety, agitation, or restlessness, and physical problems like back pain or headaches. Depression can be treated via antidepressants, mood stabilizers, or antipsychotics. The Depression pipeline market research report provides comprehensive information on the therapeutics under development for Depression, complete with analysis by stage of development, drug target, mechanism of...
-
Thematic Analysis
Digital Health in Neurology – Thematic Research
Report Overview Digital technologies are constantly evolving and finding new applications in healthcare. These tools can be used to track health, deliver therapeutic interventions, and contribute to research. They include digital therapeutics (DTx), mHealth, wearables, digital biomarkers, telemedicine, virtual reality (VR), and augmented reality (AR). For many patients living with neurological conditions, treatment can be episodic and infrequent, leaving them vulnerable. Digital health technologies provide opportunities to improve disease treatment and management for these patients, as well as being individualized...